PGNY
USDProgyny Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$18.280
Максимум
$18.840
Минимум
$18.030
Объем
0.61M
Фундаментальные показатели компании
Рыночная капитализация
1.6B
Отрасль
Healthcare Plans
Страна
United States
Статистические данные торговли
Средний объем
1.31M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 3 нояб. 2025 г.PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders
What's Happening With Progyny Right Now
Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash
Связанные новости
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs
Transcarent Experience Store Expansion: More Options for Women's Health
Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the
Progyny CEO Named World Economic Forum Champion for Women's Health
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 4 нояб. 2025 г., 17:26
64.3% Уверенность
Риск и торговля
Точка входа
$18.21
Взять прибыль
$19.66
Остановить убытки
$16.58
Ключевые факторы
Связанные акции
ALB
Albemarle Corporation
MNKD
MannKind Corporation
CMMB
Chemomab Therapeutics Ltd. American Depositary Share
SXTP
60 Degrees Pharmaceuticals Inc.
SAIC
Science Applications International Corporation
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.